Suppr超能文献

纳米材料辅助自然杀伤细胞疗法。

Nanomaterial assisted natural killer cell therapy.

作者信息

Yu Xuan, Chen Xiaobo, Yang Yanlong, Tian Yingsong, Jia Jie, Tong Xinghe

机构信息

Department of Thoracic Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.

Clinical Medical Research Center, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.

出版信息

Front Immunol. 2025 May 5;16:1558701. doi: 10.3389/fimmu.2025.1558701. eCollection 2025.

Abstract

The rising incidence of cancer has heightened interest in immune cell therapy, particularly the role of natural killer (NK) cells, which are essential components of the immune system. Their applications in tumor treatment have expanded significantly, especially with the incorporation of nanomaterials. This review comprehensively examines NK cell biology, encompassing aspects such as classification, distribution, receptor activation, and mechanisms of cytotoxicity. It also explores various NK cell therapies, including their sources, methods of acquisition, expansion techniques, Chimeric antigen receptor-Natural Killer cell (CAR-NK) technology, gene editing strategies, and combination therapies. Additionally, the review discusses the utilization of nanomaterials in NK cell therapy, focusing on nanoparticle-assisted immune regulation and the modulation of the tumor microenvironment. While NK cell therapy holds promise, CAR-NK technology presents certain limitations. The integration of nanomaterials offers potential strategies to enhance therapeutic efficacy. Future research should prioritize the optimization of NK cell therapy, address the limitations associated with CAR-NK technology, investigate the mechanisms of nanomaterials, and develop more effective nanomaterials to improve clinical outcomes.

摘要

癌症发病率的上升引发了人们对免疫细胞疗法的更大兴趣,尤其是自然杀伤(NK)细胞的作用,NK细胞是免疫系统的重要组成部分。它们在肿瘤治疗中的应用显著扩大,特别是随着纳米材料的引入。本综述全面研究了NK细胞生物学,涵盖分类、分布、受体激活和细胞毒性机制等方面。它还探讨了各种NK细胞疗法,包括其来源、获取方法、扩增技术、嵌合抗原受体自然杀伤细胞(CAR-NK)技术、基因编辑策略和联合疗法。此外,该综述讨论了纳米材料在NK细胞疗法中的应用,重点是纳米颗粒辅助的免疫调节和肿瘤微环境的调节。虽然NK细胞疗法前景广阔,但CAR-NK技术存在一定局限性。纳米材料的整合提供了增强治疗效果的潜在策略。未来的研究应优先优化NK细胞疗法,解决与CAR-NK技术相关的局限性,研究纳米材料的作用机制,并开发更有效的纳米材料以改善临床结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f89/12086159/afcd9837d7fe/fimmu-16-1558701-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验